European Commission logo
italiano italiano
CORDIS - Risultati della ricerca dell’UE
CORDIS

Doctoral training network TAu imMunE: strategies for innovative diagnosis and therapies in dementia

Descrizione del progetto

Promuovere la ricerca sull’Alzheimer per un futuro più sano

La malattia di Alzheimer e le sue controparti correlate alla tau comprendono uno spettro di disturbi neurodegenerativi caratterizzati dall’accumulo nel cervello di proteine tau anomale. Queste taupatie comprendono malattie quali, tra le altre, la paralisi sopranucleare progressiva, la degenerazione corticobasale e la demenza frontotemporale. Dato l’immenso onere che queste patologie infliggono sugli individui, sulle famiglie e sulla società in generale, la necessità impellente di diagnosi e trattamenti efficaci è innegabile. Alla luce di tali premesse, il progetto TAME, finanziato dal programma di azioni Marie Skłodowska-Curie, riunisce esperti di spicco del mondo accademico e di quello industriale per migliorare la comprensione delle malattie legate alla tau e sviluppare diagnosi e interventi più sicuri e personalizzati. Nello specifico, l’approccio multidisciplinare del progetto combina competenze in vari ambiti, quali neuroscienze molecolari, informatica, chimica e bioingegneria. Attraverso la formazione di nove scienziati di talento, il progetto pone l’accento sulla ricerca, sullo sviluppo personale e sul concetto della scienza aperta.

Obiettivo

There is an urgent medical need for efficient diagnostics for Alzheimer’s disease and related tauopathies, as well as disease modifying treatments, due to the heavy burden of the disease on patients, families and society. To address this public health issue, TAME R&I training network gathers leading academic and industrial experts in tau research with the ambition to keep older people active and independent for longer. TAME aims to provide better understanding of tau-related diseases and supports the development of new, safer, personalised and more effective diagnosis and interventions for AD and the less common tauopathies. The beneficiaries and partners bring together resources and knowledge across different fields and technologies to provide a multidisciplinary approach necessary to take on the challenge. They have teamed-up to combine molecular and cellular neuroscience with computing, chemical and bio-engineering and their technology expertise. The first tau network of Europe, TAME, will focus on novel approaches using nanobodies, which have emerged as very promising antibody formats in tau research. The primary objective of the TAME is to train 9 fellows to deliver the next generation of talented life scientists. The program will be a combination of training in research, in personal and professional development and in open science, achieved by conducting research projects, attending courses and benefiting from internal mobility within TAME. The research training is based on cutting-edge technologies and advanced models for medical research, emphasizing the need for more human-based research, gender-personalised models and reduction in the use of animals. Consequently, through intense collaboration with all partners and the relevant industrial experience, these 9 fellows can anticipate improved career prospects and higher employability. TAME will provide an innovation-friendly framework in which scientific results can mature and be developed into products.

Coordinatore

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS
Contribution nette de l'UE
€ 282 693,60
Indirizzo
RUE MICHEL ANGE 3
75794 Paris
Francia

Mostra sulla mappa

Regione
Ile-de-France Ile-de-France Paris
Tipo di attività
Research Organisations
Collegamenti
Costo totale
Nessun dato

Partecipanti (8)

Partner (13)